ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
First Trust Dorsey Wright Dynamic Focus 5 ETF
38.14
+1.05
2.83%
盘后:
38.07
-0.0700
-0.18%
16:10 EST
成交量:
2,889.00
成交额:
10.96万
市值:
1.07亿
市盈率:
- -
高:
38.14
开:
37.63
低:
37.63
收:
37.09
52周最高:
39.06
52周最低:
31.90
股本:
280.00万
流通股本:
280.00万
量比:
1.00
换手率:
0.10%
股息:
0.93
股息率:
2.45%
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻资讯
临床Ⅲ期失败,公司股价暴跌83%
佰傲谷BioValley
·
2025/09/17
东阳光药伊非尼酮II期临床取得积极结果,关键数据亮相2025第九届美国IPF峰会
智通财经网
·
2025/08/22
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/FVC"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FVC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FVC\",,,,,undefined,":{"symbol":"FVC","market":"US","secType":"STK","nameCN":"First Trust Dorsey Wright Dynamic Focus 5 ETF","latestPrice":38.14,"timestamp":1770411600000,"preClose":37.0912,"halted":0,"volume":2889,"hourTrading":{"tag":"盘后","latestPrice":38.07,"preClose":38.14,"latestTime":"16:10 EST","volume":7,"amount":266.82,"timestamp":1770412204809,"change":-0.07,"changeRate":-0.001835,"amplitude":0},"delay":0,"changeRate":0.02827624881373479,"floatShares":2800002,"shares":2800002,"eps":0,"marketStatus":"休市中","change":1.0488,"latestTime":"02-06 16:00:00 EST","open":37.63,"high":38.14,"low":37.63,"amount":109627.5544,"amplitude":0.01375,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":37.0912,"sharesOutstanding":2800002,"nav":37.08,"aum":103824074.16,"dividendRate":0.024497,"bidAskSpread":0.004886,"postHourTrading":{"tag":"盘后","latestPrice":38.07,"preClose":38.14,"latestTime":"16:10 EST","volume":7,"amount":266.82,"timestamp":1770412204809,"change":-0.07,"changeRate":-0.001835,"amplitude":0},"volumeRatio":1.0027768797388432},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FVC\",,,,,undefined,":{"symbol":"FVC","floatShares":2800002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0027768797388432,"shares":2800002,"dividePrice":0.9343,"high":38.14,"amplitude":0.01375,"preClose":37.0912,"low":37.63,"week52Low":31.9,"pbRate":"--","week52High":39.055,"institutionHeld":0,"latestPrice":38.14,"eps":0,"divideRate":0.024497,"volume":2889,"delay":0,"ttmEps":0,"open":37.63,"prevYearClose":36.368,"prevWeekClose":38.29,"prevMonthClose":38.29,"prevQuarterClose":36.368,"fiveDayClose":38.29,"twentyDayClose":37.68,"sixtyDayClose":36.0402},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FVC\",params:#limit:5,,,undefined,":[{"date":"2025-12-12","symbol":"FVC","amount":0.3232,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-31"},{"date":"2025-09-25","symbol":"FVC","amount":0.2262,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"},{"date":"2025-06-26","symbol":"FVC","amount":0.2677,"announcedDate":"2025-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-06-30"},{"date":"2025-03-27","symbol":"FVC","amount":0.1174,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-27","defaultRemindTime":1743082200000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-31","payableDate":"2025-03-27","currency":"USD","dateTimestamp":1743048000000,"payDate":"2025-03-31"},{"date":"2024-12-13","symbol":"FVC","amount":0.0275,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FVC\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-21","recordDate":"2016-09-23","paymentDate":"2016-09-30","value":0.0365,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0068,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.1017,"currency":"USD"},{"executeDate":"2017-06-22","recordDate":"2017-06-26","paymentDate":"2017-06-30","value":0.0169,"currency":"USD"},{"executeDate":"2017-09-21","recordDate":"2017-09-22","paymentDate":"2017-09-29","value":0.0459,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FVC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FVC\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2568835457","title":"临床Ⅲ期失败,公司股价暴跌83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568835457","media":"佰傲谷BioValley","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568835457?lang=zh_cn&edition=fundamental","pubTime":"2025-09-17 12:10","pubTimestamp":1758082200,"startTime":"0","endTime":"0","summary":"近日,aTyr Pharma公司公布了其核心管线Efzofitimod治疗肺结节病的Ⅲ期EFZO-FIT顶线结果。受此影响,aTyr股价直接暴跌83%。根据协议,aTyr有资格获得高达1.75亿美元的总付款,包括800万美元的预付款以及1.67亿美元的里程碑付款。2025年7月,Efzofitimod获得FDA授予的突破性疗法认定,用于系统性硬化症相关间质性肺病的治疗。EFZO-FIT是一项全球、安慰剂对照干预性Ⅲ期临床试验,共入组268名肺结节患者。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-09-17/doc-infqumnm2872501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4007","OCS","FVC"],"gpt_icon":0},{"id":"2561740358","title":"东阳光药伊非尼酮II期临床取得积极结果,关键数据亮相2025第九届美国IPF峰会","url":"https://stock-news.laohu8.com/highlight/detail?id=2561740358","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561740358?lang=zh_cn&edition=fundamental","pubTime":"2025-08-22 18:16","pubTimestamp":1755857768,"startTime":"0","endTime":"0","summary":"林博士本次报告针对伊非尼酮的II期临床研究展开,这是一项多中心、随机、安慰剂(双盲)及阳性药物(开放)平行对照的II期临床研究,旨在评价盐酸伊非尼酮片在特发性肺纤维化患者中的有效性和安全性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822181816a4984f91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822181816a4984f91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FVC"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/FVC\",params:#limit:6,delay:false,,,undefined,":[]}}